The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers
暂无分享,去创建一个
K. Kuchler | J. Fluhr | R. Plasenzotti | Anna Sobiepanek | Tomasz Kobiela | F. Siebenhaar | M. Staniszewska | Mariangela Garofalo | Ł. Kuryk | Sandeep Kumar | J. Baran | Paulina Musolf
[1] R. Bellomo,et al. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra , 2021, International journal of molecular sciences.
[2] C. González-Espinosa,et al. Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles , 2021, Frontiers in Immunology.
[3] S. Reddy,et al. Mast Cells: A New Frontier for Cancer Immunotherapy , 2021, Cells.
[4] J. Dastych,et al. The Art of Mast Cell Adhesion , 2020, Cells.
[5] B. Gartrell,et al. Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. , 2020, Kidney international.
[6] A. Jimeno,et al. Avapritinib for metastatic or unresectable gastrointestinal stromal tumors. , 2020, Drugs of today.
[7] R. Hass. Role of MSC in the Tumor Microenvironment , 2020, Cancers.
[8] J. Timmermans,et al. MRGPRX2 and Immediate Drug Hypersensitivity: Insights from Cultured Human Mast Cells. , 2020, Journal of investigational allergology & clinical immunology.
[9] M. Ernst,et al. IL33 and Mast Cells—The Key Regulators of Immune Responses in Gastrointestinal Cancers? , 2020, Frontiers in Immunology.
[10] P. Conti,et al. Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37 , 2020, International journal of molecular sciences.
[11] S. Meri,et al. Mast cells and complement system: Ancient interactions between components of innate immunity , 2020, Allergy.
[12] J. Bi,et al. IL-37 is protective in allergic contact dermatitis through mast cell inhibition. , 2020, International immunopharmacology.
[13] S. Frischbutter,et al. Skin Mast Cells Contribute to Sporothrix schenckii Infection , 2020, Frontiers in Immunology.
[14] Sohita Dhillon. Avapritinib: First Approval , 2020, Drugs.
[15] S. Martinotti,et al. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37. , 2020, European journal of pharmacology.
[16] Mark G. Papich. Masitinib Mesylate , 2020, Papich Handbook of Veterinary Drugs.
[17] N. Pullen,et al. Beyond IgE: Alternative Mast Cell Activation Across Different Disease States , 2020, International journal of molecular sciences.
[18] L. Bielory,et al. Mast Cell Biology at Molecular Level: a Comprehensive Review , 2019, Clinical Reviews in Allergy & Immunology.
[19] J. Ritchey,et al. Human Mast Cell Development from Hematopoietic Stem Cells in a Connective Tissue-Equivalent Model. , 2019, Tissue engineering. Part A.
[20] R. Jessberger,et al. Regulation of the pleiotropic effects of tissue-resident mast cells. , 2019, The Journal of allergy and clinical immunology.
[21] C. Taube,et al. Mast cells drive IgE-mediated disease but may be bystanders in many other inflammatory and neoplastic conditions. , 2019, The Journal of allergy and clinical immunology.
[22] S. Galli,et al. Mast cells are critical for controlling the bacterial burden and the healing of infected wounds , 2019, Proceedings of the National Academy of Sciences.
[23] Yongfei Wang,et al. Activation of Mast Cells Promote Plasmodium berghei ANKA Infection in Murine Model , 2019, Front. Cell. Infect. Microbiol..
[24] C. Sommerhoff,et al. Exosome-mediated uptake of mast cell tryptase into the nucleus of melanoma cells: a novel axis for regulating tumor cell proliferation and gene expression , 2019, Cell Death & Disease.
[25] J. Marshall,et al. Mast Cell Responses to Viruses and Pathogen Products , 2019, International journal of molecular sciences.
[26] F. Redegeld,et al. Role of Mast Cells in Shaping the Tumor Microenvironment , 2019, Clinical Reviews in Allergy & Immunology.
[27] M. Hibbs,et al. IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization , 2019, Nature Communications.
[28] A. Piliponsky,et al. Mast Cells in Viral, Bacterial, and Fungal Infection Immunity , 2019, International journal of molecular sciences.
[29] E. Mendez-Enriquez,et al. Mast Cells and Their Progenitors in Allergic Asthma , 2019, Front. Immunol..
[30] F. Granata,et al. Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019 , 2019, International Archives of Allergy and Immunology.
[31] Shravan Morla. Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation , 2019, International journal of molecular sciences.
[32] P. Conti,et al. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. , 2019, Journal of biological regulators and homeostatic agents.
[33] T. Sumpter,et al. Cutaneous immune responses mediated by dendritic cells and mast cells. , 2019, JCI insight.
[34] C. Pucillo,et al. Mast Cells Respond to Candida albicans Infections and Modulate Macrophages Phagocytosis of the Fungus , 2018, Front. Immunol..
[35] E. Sztul,et al. Role of Host Cell Secretory Machinery in Zika Virus Life Cycle , 2018, Viruses.
[36] L. Bjermer,et al. Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2 , 2018, Cell Communication and Signaling.
[37] C. Mathias,et al. The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets , 2018, Front. Immunol..
[38] M. Simon,et al. Genetic and metabolic hallmarks of clear cell renal cell carcinoma. , 2018, Biochimica et biophysica acta. Reviews on cancer.
[39] J. Renauld,et al. IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut , 2018, Cell reports.
[40] Di Zhang,et al. Critical roles of TRPV2 channels, histamine H1 and adenosine A1 receptors in the initiation of acupoint signals for acupuncture analgesia , 2018, Scientific Reports.
[41] M. Harnett,et al. IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62 , 2018, Scientific Reports.
[42] M. Tsai,et al. Mast cells as sources of cytokines, chemokines, and growth factors , 2018, Immunological reviews.
[43] F. Redegeld,et al. Non‐IgE mediated mast cell activation , 2018, Immunological reviews.
[44] E. Fuentes-Pananá,et al. Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer , 2018, Journal of immunology research.
[45] F. Redegeld,et al. Mast Cells as Drivers of Disease and Therapeutic Targets. , 2017, Trends in immunology.
[46] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[47] M. Colombo,et al. Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses. , 2017, Trends in immunology.
[48] F. Levi-Schaffer,et al. Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer , 2017, Front. Med..
[49] Zuojiong Gong,et al. HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs , 2017, Oncology letters.
[50] S. Deb,et al. Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy? , 2017, Journal of Cancer Research and Clinical Oncology.
[51] Irina Leonardi,et al. Fungal dysbiosis: immunity and interactions at mucosal barriers , 2017, Nature Reviews Immunology.
[52] K. Kullander,et al. SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivo , 2017, Scientific Reports.
[53] F. Granata,et al. Are Mast Cells MASTers in Cancer? , 2017, Front. Immunol..
[54] Yi Yao,et al. SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway , 2017, International journal of oncology.
[55] J. Renauld,et al. A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis , 2017, Nature Communications.
[56] S. Shibata,et al. Regulation of plasma histamine levels by the mast cell clock and its modulation by stress , 2017, Scientific Reports.
[57] A. Kadi,et al. Identification and characterization of in vitro phase I and reactive metabolites of masitinib using a LC-MS/MS method: bioactivation pathway elucidation , 2017 .
[58] M. Maurer,et al. Mast Cells Limit the Exacerbation of Chronic Allergic Contact Dermatitis in Response to Repeated Allergen Exposure , 2016, The Journal of Immunology.
[59] V. Barresi,et al. Mast Cell Interaction with Neutrophils in Human Gastric Carcinomas: Ultrastructural Observations , 2016, Analytical cellular pathology.
[60] M. Triggiani,et al. Mast cells as effector cells of innate immunity and regulators of adaptive immunity. , 2016, Immunology letters.
[61] E. Russo,et al. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment. , 2016, Cancer letters.
[62] N. Shenoy,et al. Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[63] M. Saleem,et al. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells , 2016, Drug design, development and therapy.
[64] D. Voehringer,et al. Mucosal mast cells are indispensable for the timely termination of Strongyloides ratti infection , 2016, Mucosal Immunology.
[65] F. Awan,et al. Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis. , 2016, The New England journal of medicine.
[66] D. Metcalfe,et al. IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3. , 2016, The Journal of allergy and clinical immunology.
[67] E. Giovannetti,et al. Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective , 2016, Cancer Chemotherapy and Pharmacology.
[68] Ailin Tao,et al. Mast Cell Targeted Chimeric Toxin Can Be Developed as an Adjunctive Therapy in Colon Cancer Treatment , 2016, Toxins.
[69] F. Cunha,et al. Mast cells phagocyte Candida albicans and produce nitric oxide by mechanisms involving TLR2 and Dectin-1. , 2016, Immunobiology.
[70] J. Landsberg,et al. A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells. , 2016, Cancer research.
[71] J. Wood,et al. Mast Cell: A Multi-Functional Master Cell , 2016, Front. Immunol..
[72] H. Raifer,et al. Mast cells have no impact on cutaneous leishmaniasis severity and related Th2 differentiation in resistant and susceptible mice , 2016, European journal of immunology.
[73] R. Sironen,et al. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma , 2015, Melanoma research.
[74] M. Colombo,et al. The Role of Mast Cells in Molding the Tumor Microenvironment , 2015, Cancer Microenvironment.
[75] I. Estrada-García,et al. Recognition of Candida albicans by Dectin-1 induces mast cell activation. , 2015, Immunobiology.
[76] Linda A. Lindsay. Type I Hypersensitivity Reaction , 2015 .
[77] L. Marti,et al. Chemokines and immunity , 2015, Einstein.
[78] G. Marone,et al. Tumor-Associated Mast Cells in Thyroid Cancer , 2015, International journal of endocrinology.
[79] S. Bulfone-Paus,et al. Mast Cells as Regulators of T Cell Responses , 2015, Front. Immunol..
[80] G. Nilsson,et al. Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells , 2015, Scientific Reports.
[81] H. Kiyono,et al. Pathophysiological Role of Extracellular Purinergic Mediators in the Control of Intestinal Inflammation , 2015, Mediators of inflammation.
[82] Joakim S. Dahlin,et al. Distinguishing Mast Cell Progenitors from Mature Mast Cells in Mice , 2015, Stem cells and development.
[83] I. Moura,et al. The role of mast cells in cancers , 2015, F1000prime reports.
[84] S. Thomsen. Epidemiology and natural history of atopic diseases , 2015, European clinical respiratory journal.
[85] T. Moon,et al. Mast Cell Mediators: Their Differential Release and the Secretory Pathways Involved , 2014, Front. Immunol..
[86] J. Davoust,et al. Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis. , 2014, The Journal of clinical investigation.
[87] Sakuo Yamada,et al. Does β-Hexosaminidase Function Only as a Degranulation Indicator in Mast Cells? The Primary Role of β-Hexosaminidase in Mast Cell Granules , 2014, The Journal of Immunology.
[88] Cheng Huang,et al. Lipopolysaccharide/adenosine triphosphate induces IL‑1β and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells. , 2014, International journal of molecular medicine.
[89] J. Brugarolas. Molecular genetics of clear-cell renal cell carcinoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] G. Pejler,et al. Mast cell secretory granules: armed for battle , 2014, Nature Reviews Immunology.
[91] M. Maurer,et al. Mast cells protect from skin tumor development and limit tumor growth during cutaneous de novo carcinogenesis in a Kit‐dependent mouse model , 2014, Experimental dermatology.
[92] G. Newton,et al. Leukocyte recruitment in inflammation: basic concepts and new mechanistic insights based on new models and microscopic imaging technologies , 2014, Cell and Tissue Research.
[93] G. Stefanzl,et al. The pan‐Bcl‐2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells , 2014, Journal of leukocyte biology.
[94] C. Parish,et al. Heparan Sulfate: A Ubiquitous Glycosaminoglycan with Multiple Roles in Immunity , 2013, Front. Immunol..
[95] G. Sammarco,et al. Mast Cells Positive to Tryptase and c-Kit Receptor Expressing Cells Correlates with Angiogenesis in Gastric Cancer Patients Surgically Treated , 2013, Gastroenterology research and practice.
[96] Stephen J Galli,et al. Mast Cells: Potential Positive and Negative Roles in Tumor Biology , 2013, Cancer Immunology Research.
[97] T. Wilgus,et al. Mast cell activity in the healing wound: more than meets the eye? , 2013, Experimental dermatology.
[98] R. Hwang,et al. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. , 2013, Cancer research.
[99] L. Kjellén,et al. Pathophysiology of heparan sulphate: many diseases, few drugs , 2013, Journal of internal medicine.
[100] D. Ribatti. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis. , 2013, Immunology letters.
[101] Trees Jansen,et al. Candida albicans Primes TLR Cytokine Responses through a Dectin-1/Raf-1–Mediated Pathway , 2013, The Journal of Immunology.
[102] D. Voehringer. Protective and pathological roles of mast cells and basophils , 2013, Nature Reviews Immunology.
[103] T. Standiford,et al. Bruton's tyrosine kinase mediates FcγRIIa/Toll-like receptor-4 receptor crosstalk in human neutrophils. , 2013, American journal of respiratory cell and molecular biology.
[104] T. Moon,et al. Limited replication of influenza A virus in human mast cells , 2012, Immunologic Research.
[105] F. Liew,et al. Interleukin-33 and the function of innate lymphoid cells. , 2012, Trends in immunology.
[106] H. Rodewald,et al. Widespread immunological functions of mast cells: fact or fiction? , 2012, Immunity.
[107] D. Conrad,et al. Cutting Edge: Mast Cells Critically Augment Myeloid-Derived Suppressor Cell Activity , 2012, The Journal of Immunology.
[108] C. Pucillo,et al. Mast Cell: An Emerging Partner in Immune Interaction , 2012, Front. Immun..
[109] M. Tsai,et al. IgE and mast cells in allergic disease , 2012, Nature Medicine.
[110] S. Hartmann,et al. Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines , 2012, Proceedings of the National Academy of Sciences.
[111] D. Sheppard,et al. The Role of Mast Cells in the Defence against Pathogens , 2012, PLoS pathogens.
[112] K. Ravid,et al. Mast Cell Adenosine Receptors Function: A Focus on the A3 Adenosine Receptor and Inflammation , 2012, Front. Immun..
[113] M. Matho,et al. Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy. , 2012, The Journal of clinical investigation.
[114] P. Hwu,et al. Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal Adenocarcinoma , 2011, Clinical Cancer Research.
[115] G. Nilsson,et al. Mast cells as regulators of skin inflammation and immunity. , 2011, Acta dermato-venereologica.
[116] G. Nilsson,et al. Mast cells generated from patients with atopic eczema have enhanced levels of granule mediators and an impaired Dectin‐1 expression , 2011, Allergy.
[117] M. Santoro,et al. Mast cells have a protumorigenic role in human thyroid cancer , 2010, Oncogene.
[118] Robert Anderson,et al. Dengue Virus Infection of Mast Cells Triggers Endothelial Cell Activation , 2010, Journal of Virology.
[119] S. Abraham,et al. Role of Mast Cells in Inflammatory Bowel Disease and Inflammation-Associated Colorectal Neoplasia in IL-10-Deficient Mice , 2010, PloS one.
[120] Gunnar Pejler,et al. Mast cell proteases: multifaceted regulators of inflammatory disease. , 2010, Blood.
[121] S. Abraham,et al. Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.
[122] L. Hartmann,et al. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. , 2010, Cancer research.
[123] R. Liblau,et al. Cell-cell cooperation at the T helper cell/mast cell immunological synapse. , 2009, Blood.
[124] B. Guss,et al. Infection of Mast Cells with Live Streptococci Causes a Toll-Like Receptor 2- and Cell-Cell Contact-Dependent Cytokine and Chemokine Response , 2009, Infection and Immunity.
[125] C. Kunder,et al. Mast cell–derived particles deliver peripheral signals to remote lymph nodes , 2009, The Journal of experimental medicine.
[126] D. Metcalfe,et al. Mechanisms of mast cell signaling in anaphylaxis. , 2009, The Journal of allergy and clinical immunology.
[127] W. Sippl,et al. Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT , 2009, PloS one.
[128] I. Brodsky,et al. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. , 2009, Seminars in immunology.
[129] T. Vlaykova,et al. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer , 2009, Journal of gastroenterology and hepatology.
[130] G. Sauter,et al. Immunological microenvironment in prostate cancer: High mast cell densities are associated with favorable tumor characteristics and good prognosis , 2009, The Prostate.
[131] G. Nilsson,et al. TLR2/MyD88-Dependent and -Independent Activation of Mast Cell IgE Responses by the Skin Commensal Yeast Malassezia sympodialis1 , 2009, The Journal of Immunology.
[132] G. Alí,et al. Tryptase Mast Cells in Malignant Pleural Mesothelioma as an Independent Favorable Prognostic Factor , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[133] A. Zychlinsky,et al. Mouse Neutrophil Extracellular Traps in Microbial Infections , 2009, Journal of Innate Immunity.
[134] F. Sinicrope,et al. BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells , 2009, Clinical Cancer Research.
[135] G. Hutchins,et al. Nf1-Dependent Tumors Require a Microenvironment Containing Nf1 +/−- and c-kit-Dependent Bone Marrow , 2008, Cell.
[136] Stephen J. Galli,et al. The development of allergic inflammation , 2008, Nature.
[137] M. Tsai,et al. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity , 2008, Nature Reviews Immunology.
[138] K. Yamauchi,et al. Progress in allergy signal research on mast cells: the role of histamine in goblet cell hyperplasia in allergic airway inflammation - a study using the Hdc knockout mouse. , 2008, Journal of pharmacological sciences.
[139] C. Mackay,et al. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2 , 2008, Immunology and cell biology.
[140] M. Metintaş,et al. The Significance and Relationship between Mast Cells and Tumour Angiogenesis in Non-small Cell Lung Carcinoma , 2008, The Journal of international medical research.
[141] M. D. de Lutiis,et al. Role of mast cells in tumor growth. , 2007, Annals of clinical and laboratory science.
[142] K. Aozasa,et al. Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer , 2007, British Journal of Cancer.
[143] I. Bachelet,et al. Mast cells as effector cells: a co-stimulating question. , 2007, Trends in immunology.
[144] D. Jäger,et al. Intratumoural injection of the toll-like receptor-2/6 agonist ‘macrophage-activating lipopeptide-2’ in patients with pancreatic carcinoma: a phase I/II trial , 2007, British Journal of Cancer.
[145] R. Adachi,et al. Mast Cell-restricted Tryptases: Structure and Function in Inflammation and Pathogen Defense* , 2007, Journal of Biological Chemistry.
[146] G. Caughey. Mast cell tryptases and chymases in inflammation and host defense , 2007, Immunological reviews.
[147] R. Sagi-Eisenberg. The mast cell: where endocytosis and regulated exocytosis meet , 2007, Immunological reviews.
[148] M. Maurer,et al. Skin mast cells control T cell‐dependent host defense in Leishmania major infections , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[149] S. Mäkinen‐Kiljunen,et al. Clustered sensitivity to fungi: anaphylactic reactions caused by ingestive allergy to yeasts. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[150] L. Hellman,et al. Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution , 2006, Immunogenetics.
[151] J. Mestan,et al. AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL , 2006, British Journal of Cancer.
[152] F. Brennan,et al. Bruton’s Tyrosine Kinase Is Required for TLR2 and TLR4-Induced TNF, but Not IL-6, Production1 , 2006, The Journal of Immunology.
[153] D. McDonald,et al. Mast cells protect mice from Mycoplasma pneumonia. , 2006, American journal of respiratory and critical care medicine.
[154] G. Nilsson,et al. Angiogenesis and mast cells in Hodgkin lymphoma , 2005, Leukemia.
[155] H. Sudhoff,et al. Role of mast cells in otitis media. , 2005, The Journal of allergy and clinical immunology.
[156] P. Disaia,et al. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. , 2005, Gynecologic oncology.
[157] C. Cetrulo,et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells , 2005, British journal of pharmacology.
[158] J. Wedemeyer,et al. Decreased susceptibility of mast cell-deficient KitW/KitW-v mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors , 2005, Laboratory Investigation.
[159] Zhi-xiang Shen,et al. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. , 2005, World journal of gastroenterology.
[160] J. Norgauer,et al. H1 histamine receptor mediates inflammatory responses in human keratinocytes. , 2004, The Journal of allergy and clinical immunology.
[161] A. Brill,et al. Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[162] H. Matsue,et al. The effects of endothelin‐1 on degranulation, cytokine, and growth factor production by skin‐derived mast cells , 2004, European journal of immunology.
[163] P. Conti,et al. Mast cells: the Jekyll and Hyde of tumor growth. , 2004, Trends in immunology.
[164] F. Villinger,et al. Signaling through Toll-Like Receptors Triggers HIV-1 Replication in Latently Infected Mast Cells1 , 2004, The Journal of Immunology.
[165] Shizuo Akira,et al. TLR signaling pathways. , 2004, Seminars in immunology.
[166] G. W. Wong,et al. Mouse Chromosome 17A3.3 Contains 13 Genes That Encode Functional Tryptic-like Serine Proteases with Distinct Tissue and Cell Expression Patterns* , 2004, Journal of Biological Chemistry.
[167] M. Samoszuk,et al. Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer , 2003, International journal of cancer.
[168] R. Hernández-Pando,et al. Mast Cell Activation by Mycobacterium tuberculosis: Mediator Release and Role of CD48 1 , 2003, The Journal of Immunology.
[169] H. Okabe,et al. Gabexate Mesilate, a Synthetic Protease Inhibitor, Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Inhibiting Activation of Both Nuclear Factor-κB and Activator Protein-1 in Human Monocytes , 2003, Journal of Pharmacology and Experimental Therapeutics.
[170] I. Biaggioni,et al. Mast Cell–Mediated Stimulation of Angiogenesis: Cooperative Interaction Between A2B and A3 Adenosine Receptors , 2003, Circulation research.
[171] L. Björck,et al. Immunoglobulin Superantigen Protein L Induces IL-4 and IL-13 Secretion from Human FcεRI+ Cells Through Interaction with the κ Light Chains of IgE 1 , 2003, The Journal of Immunology.
[172] Nathan Chandler,et al. Corticotropin-Releasing Hormone and Brain Mast Cells Regulate Blood-Brain-Barrier Permeability Induced by Acute Stress , 2002, Journal of Pharmacology and Experimental Therapeutics.
[173] V. Meineke,et al. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: Possible relevance to human fibrotic disorders , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[174] M. Papich. Saunders Handbook of Veterinary Drugs , 2002 .
[175] A. Demircan,et al. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. , 2001, Journal of clinical pathology.
[176] J. Cherrington,et al. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. , 2001, Blood.
[177] C. Lawrence,et al. Delayed Expulsion of the Nematode Trichinella spiralisIn Mice Lacking the Mucosal Mast Cell–Specific Granule Chymase, Mouse Mast Cell Protease-1 , 2000, The Journal of experimental medicine.
[178] S. Jimi,et al. Increased Density of Interstitial Mast Cells in Amyloid A Renal Amyloidosis , 2000, Modern Pathology.
[179] S. Jimi,et al. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. , 2000, Human pathology.
[180] T. Kudo,et al. Nafamostat mesilate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apoptosis in cultured human trophoblasts. , 2000, Life sciences.
[181] P. Cui,et al. Chymase is a potent chemoattractant for human monocytes and neutrophils , 2000, Journal of leukocyte biology.
[182] K. Manova,et al. Point mutation in Kit receptor tyrosine kinase reveals essential roles for Kit signaling in spermatogenesis and oogenesis without affecting other Kit responses , 2000, The EMBO journal.
[183] K. Tryggvason,et al. The macrophage receptor MARCO. , 2000, Microbes and infection.
[184] J. Kinet,et al. Signalling through the high-affinity IgE receptor FcεRI , 1999, Nature.
[185] T. Kawakami,et al. Functions of Bruton's tyrosine kinase in mast and B cells , 1999, Journal of leukocyte biology.
[186] M. Stack,et al. Proteinase requirements of epidermal growth factor–induced ovarian cancer cell invasion , 1998, International journal of cancer.
[187] P. Arvan,et al. Sorting and storage during secretory granule biogenesis: looking backward and looking forward. , 1998, The Biochemical journal.
[188] Michael Loran Dustin,et al. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic , 1997, Nature.
[189] S. Ren,et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. , 1997, The Journal of clinical investigation.
[190] D. Friend,et al. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype , 1996, The Journal of cell biology.
[191] R. Edwards,et al. Transport of histamine by vesicular monoamine transporter-2 , 1995, Neuropharmacology.
[192] B. Dewald,et al. Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytes , 1995 .
[193] I. Taşdemir,et al. Intestinal protection against Strongyloides ratti and mastocytosis induced by administration of interleukin-3 in mice. , 1993, Immunology.
[194] Y. Horii,et al. Mucosal mast cells and the expulsive mechanisms of mice against Strongyloides venezuelensis. , 1993, International journal for parasitology.
[195] R. D. Hanson,et al. The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. , 1993, Genomics.
[196] H. Kelly,et al. Cromolyn Sodium: A Review of Mechanisms and Clinical Use in Asthma , 1987, Drug intelligence & clinical pharmacy.
[197] H. Müller-Eberhard,et al. Release of histamine from rat mast cells by the complement peptides C3a and C5a. , 1975, Immunology.
[198] G. Asboe-hansen. Mast cells in health and disease. , 1968, Bulletin of the New York Academy of Medicine.
[199] W. Gong,et al. The Critical Role of the Antimicrobial Peptide LL-37/ CRAMP in Protection of Colon Microbiota Balance, Mucosal Homeostasis, Anti-Inflammatory Responses, and Resistance to Carcinogenesis. , 2019, Critical reviews in immunology.
[200] Joakim S. Dahlin,et al. Mast cell progenitors: origin, development and migration to tissues. , 2015, Molecular immunology.
[201] N. Hogg,et al. PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Mast cell and macrophage chemokines CXCL 1 / CXCL 2 control the early stage of neutrophil recruitment during tissue in fl ammation , 2013 .
[202] R. Benezra,et al. Chapter Fifteen – Targeting Protein–Protein Interactions to Treat Cancer—Recent Progress and Future Directions , 2013 .
[203] K. Amin. The role of mast cells in allergic inflammation. , 2012, Respiratory medicine.
[204] M. E. Walker,et al. New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? , 2012, Biochimica et biophysica acta.
[205] M. Tsai,et al. Mast cells and immunoregulation/immunomodulation. , 2011, Advances in experimental medicine and biology.
[206] G. Caughey. Mast cell proteases as protective and inflammatory mediators. , 2011, Advances in experimental medicine and biology.
[207] A. Sica,et al. Tumor promotion by tumor-associated macrophages. , 2007, Advances in experimental medicine and biology.
[208] S. Ch’ng,et al. Mast cells and cutaneous malignancies , 2006, Modern Pathology.
[209] E. Voest,et al. TUMOR VASCULATURE AS A TARGET , 2002 .
[210] R. Kokenyesi. Ovarian carcinoma cells synthesize both chondroitin sulfate and heparan sulfate cell surface proteoglycans that mediate cell adhesion to interstitial matrix , 2001, Journal of cellular biochemistry.
[211] F. Levi-Schaffer,et al. Mast cells and fibroblasts: two interacting cells , 1994, International journal of clinical & laboratory research.
[212] G. Pinkus,et al. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology , 2022 .